| P2093 | author name string | Silvia Lai | |
| | Bettina Coppola | |
| P2860 | cites work | Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes | Q28193103 |
| | Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency | Q33242018 |
| | Enoxaparin and bleeding complications: a review in patients with and without renal insufficiency | Q33977626 |
| | Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials | Q35972979 |
| | No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease. | Q43879938 |
| | Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation | Q44690169 |
| | Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT). | Q44895519 |
| | Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time | Q44903699 |
| | The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison | Q59651031 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 433-436 | |
| P577 | publication date | 2013-09-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Use of enoxaparin in end-stage renal disease | |
| P478 | volume | 84 | |